[{"orgOrder":0,"company":"Fauqu\u00e9","sponsor":"Institut Polyclinique de Cannes (IPOCA)","pharmaFlowCategory":"DU","therapeuticArea":"Nutrition and Weight Loss","country":"","productType":"Miscellaneous","year":"2020","type":"Inapplicable","leadProduct":"Alpha Lipoic Acid","moa":"Lipoyl amidotransferase LIPT1, mitochondrial; Sodium-dependent multivitamin transporter; Lipoyl synthase, mitochondrial","graph1":"Nutrition and Weight Loss","graph2":"Undisclosed","graph3":"Fauqu\u00e9","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Nutrition & Weight Loss","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Fauqu\u00e9 \/ Institut Polyclinique de Cannes (IPOCA)","highestDevelopmentStatusID":"1","companyTruncated":"Fauqu\u00e9 \/ Institut Polyclinique de Cannes (IPOCA)"},{"orgOrder":0,"company":"Universiti Sains Malaysia","sponsor":"BREGO Life Sciences","pharmaFlowCategory":"DU","therapeuticArea":"Neurology","country":"MALAYSIA","productType":"Miscellaneous","year":"2024","type":"Inapplicable","leadProduct":"Alpha Lipoic Acid","moa":"Lipoyl amidotransferase LIPT1, mitochondrial; Sodium-dependent multivitamin transporter; Lipoyl synthase, mitochondrial","graph1":"Neurology","graph2":"Phase II","graph3":"Universiti Sains Malaysia","amount2":0,"highestDevelopmentShortName":"Ph II","therapeuticAreaShortName":"Neurology","amount2New":0,"dosageForm":"Film, Soluble","sponsorNew":"Universiti Sains Malaysia \/ BREGO Life Sciences","highestDevelopmentStatusID":"8","companyTruncated":"Universiti Sains Malaysia \/ BREGO Life Sciences"},{"orgOrder":0,"company":"Ain Shams University","sponsor":"Eva Pharma","pharmaFlowCategory":"DU","therapeuticArea":"Nephrology","country":"EGYPT","productType":"Miscellaneous","year":"2024","type":"Inapplicable","leadProduct":"Alpha Lipoic Acid","moa":"Lipoyl amidotransferase LIPT1, mitochondrial; Sodium-dependent multivitamin transporter; Lipoyl synthase, mitochondrial","graph1":"Nephrology","graph2":"Phase III","graph3":"Ain Shams University","amount2":0,"highestDevelopmentShortName":"Ph III","therapeuticAreaShortName":"Nephrology","amount2New":0,"dosageForm":"Tablet","sponsorNew":"Ain Shams University \/ Eva Pharma","highestDevelopmentStatusID":"10","companyTruncated":"Ain Shams University \/ Eva Pharma"},{"orgOrder":0,"company":"Eva Pharma","sponsor":"MARC-CRO","pharmaFlowCategory":"DU","therapeuticArea":"Neurology","country":"EGYPT","productType":"Miscellaneous","year":"2023","type":"Inapplicable","leadProduct":"Alpha Lipoic Acid","moa":"Lipoyl amidotransferase LIPT1, mitochondrial; Sodium-dependent multivitamin transporter; Lipoyl synthase, mitochondrial","graph1":"Neurology","graph2":"Phase IV","graph3":"Eva Pharma","amount2":0,"highestDevelopmentShortName":"Ph IV","therapeuticAreaShortName":"Neurology","amount2New":0,"dosageForm":"Tablet","sponsorNew":"Eva Pharma \/ MARC-CRO","highestDevelopmentStatusID":"11","companyTruncated":"Eva Pharma \/ MARC-CRO"},{"orgOrder":0,"company":"Ilko Ila\u00e7 Sanayi ve Ticaret A.S","sponsor":"Undisclosed","pharmaFlowCategory":"DU","therapeuticArea":"Neurology","country":"TURKEY","productType":"Miscellaneous","year":"2020","type":"Inapplicable","leadProduct":"Alpha Lipoic Acid","moa":"Lipoyl amidotransferase LIPT1, mitochondrial; Sodium-dependent multivitamin transporter; Lipoyl synthase, mitochondrial","graph1":"Neurology","graph2":"Phase I","graph3":"Ilko Ila\u00e7 Sanayi ve Ticaret A.S","amount2":0,"highestDevelopmentShortName":"Ph I","therapeuticAreaShortName":"Neurology","amount2New":0,"dosageForm":"Tablet, Film Coated","sponsorNew":"Ilko Ila\u00e7 Sanayi ve Ticaret A.S \/ Undisclosed","highestDevelopmentStatusID":"6","companyTruncated":"Ilko Ila\u00e7 Sanayi ve Ticaret A.S \/ Undisclosed"}]

Find Clinical Drug Pipeline Developments & Deals for Alpha Lipoic Acid

Menu
Xls
Filters Filter
×
FILTER:
filter
Company Name
    filter

    Year

      filter

      DEALS // DEV.

        filter

        Country

          filter
          Sponsor
            filter

            Therapeutic Area

              filter

              Study Phase

                filter

                Deal Type

                  filter

                  Product Type

                    filter

                    Dosage Form

                      filter

                      Lead Product

                        filter

                        Target

                          Loading...

                          Therapeutic Area by Lead Product

                          Study Phase by Lead Product

                          Company by Lead Product

                          Top Deals by Deal Size (USD bn)

                          01

                          Universiti Sains Malaysia

                          Country arrow
                          Luxepack
                          Not Confirmed

                          Universiti Sains Malaysia

                          Country arrow
                          Luxepack
                          Not Confirmed

                          Details : Alpha-lipoic acid is a Other Small Molecule drug candidate, which is currently being evaluated in phase II clinical studies for the treatment of Diabetic Neuropathies.

                          Product Name : Undisclosed

                          Product Type : Miscellaneous

                          Upfront Cash : Inapplicable

                          August 23, 2024

                          Lead Product(s) : Alpha Lipoic Acid

                          Therapeutic Area : Neurology

                          Highest Development Status : Phase II

                          Sponsor : BREGO Life Sciences

                          Deal Size : Inapplicable

                          Deal Type : Inapplicable

                          blank

                          02

                          Ain Shams University

                          Country arrow
                          Luxepack
                          Not Confirmed

                          Ain Shams University

                          Country arrow
                          Luxepack
                          Not Confirmed

                          Details : Alpha-lipoic acid is a Other Small Molecule drug candidate, which is currently being evaluated in phase III clinical studies for the treatment of Kidney Diseases.

                          Product Name : Undisclosed

                          Product Type : Miscellaneous

                          Upfront Cash : Inapplicable

                          February 29, 2024

                          Lead Product(s) : Alpha Lipoic Acid

                          Therapeutic Area : Nephrology

                          Highest Development Status : Phase III

                          Sponsor : Eva Pharma

                          Deal Size : Inapplicable

                          Deal Type : Inapplicable

                          blank

                          03

                          Luxepack
                          Not Confirmed
                          Luxepack
                          Not Confirmed

                          Details : Alpha-lipoic acid is a Other Small Molecule drug candidate, which is currently being evaluated in phase IV clinical studies for the treatment of Diabetic Neuropathies.

                          Product Name : Undisclosed

                          Product Type : Miscellaneous

                          Upfront Cash : Inapplicable

                          April 14, 2023

                          Lead Product(s) : Alpha Lipoic Acid

                          Therapeutic Area : Neurology

                          Highest Development Status : Phase IV

                          Sponsor : MARC-CRO

                          Deal Size : Inapplicable

                          Deal Type : Inapplicable

                          blank

                          04

                          Fauqué

                          Country arrow
                          Luxepack
                          Not Confirmed

                          Fauqué

                          Country arrow
                          Luxepack
                          Not Confirmed

                          Details : Alpha Lipoic Acid is a Other Small Molecule drug candidate, which is currently being evaluated in clinical studies for the treatment of Obesity.

                          Product Name : Undisclosed

                          Product Type : Miscellaneous

                          Upfront Cash : Inapplicable

                          June 18, 2020

                          Lead Product(s) : Alpha Lipoic Acid

                          Therapeutic Area : Nutrition and Weight Loss

                          Highest Development Status : Undisclosed

                          Sponsor : Institut Polyclinique de Cannes (IPOCA)

                          Deal Size : Inapplicable

                          Deal Type : Inapplicable

                          blank

                          05

                          Luxepack
                          Not Confirmed
                          Luxepack
                          Not Confirmed

                          Details : Alpha-lipoic acid is a Other Small Molecule drug candidate, which is currently being evaluated in phase I clinical studies for the treatment of Diabetic Neuropathies.

                          Product Name : Undisclosed

                          Product Type : Miscellaneous

                          Upfront Cash : Inapplicable

                          January 02, 2020

                          Lead Product(s) : Alpha Lipoic Acid

                          Therapeutic Area : Neurology

                          Highest Development Status : Phase I

                          Sponsor : Undisclosed

                          Deal Size : Inapplicable

                          Deal Type : Inapplicable

                          blank

                          06

                          Luxepack
                          Not Confirmed
                          Luxepack
                          Not Confirmed

                          Details : Lipoic Acid is a Other Small Molecule drug candidate, which is currently being evaluated in phase II/ phase III clinical studies for the treatment of Diabetes Mellitus.

                          Product Name : Undisclosed

                          Product Type : Miscellaneous

                          Upfront Cash : Inapplicable

                          October 20, 2010

                          Lead Product(s) : Alpha Lipoic Acid

                          Therapeutic Area : Endocrinology

                          Highest Development Status : Phase II/ Phase III

                          Sponsor : Undisclosed

                          Deal Size : Inapplicable

                          Deal Type : Inapplicable

                          blank